EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

Sandrine Venier iD, Pascal Defaye iD, Lisa Lochon iD, Rémi Benali, Arnaud Bisson iD, Adrien Carabelli iD, Youssou Diouf iD, Peggy Jacon iD, Laurent Fauchier iD

Circulation: Arrhythmia and Electrophysiology · 2026-01 · 19 (1)

DOI: 10.1161/circep.125.014101 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026-01. Verfasst von Sandrine Venier und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Grenoble Alpes University Hospital, Grenoble, France (S.V., P.D., R.B., A.C., Y.D., P.J.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Glucagon-Like Peptide-1 Receptor Agonists, Incretins. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: GLP-1 (glucagon-like peptide-1) receptor agonists (GLP-1RAs), initially developed for glycemic control in type 2 diabetes, have shown cardiometabolic benefits including weight loss, improved endothelial function, and reduced inflammation. Recent data suggest potential anti-arrhythmic effects via modulation of atrial substrate and autonomic tone. Their impact on obese, nondiabetic patients remains underexplored. This study examines whether GLP-1RA use is associated with reduced atrial fibrillation recurrence after catheter ablation in obese patients, using real-world data from a large multicenter database. METHODS: We conducted a retrospective cohort study using the TriNetX research network, which contains de-identified electronic health records from >100 million patients. Adult patients (age ≥18 years) with obesity (body mass index >30 kg/m²) who underwent atrial fibrillation (AF) ablation between January 2015 and January 2025 were eligible. The cohort was divided into GLP-1RA users (n=3350) and nonusers (n=3350), with 1:1 propensity score matching performed across 82 clinical and demographic variables, including age, sex, race, AF subtype, cardiovascular comorbidities, and baseline medications. RESULTS: During a median follow-up of 2 years (interquartile range, 0.8–3.2) AF recurrence was significantly lower in GLP-1RA users versus non users (6.66% versus 7.72%; hazard ratio [HR], 0.82 [95% CI, 0.76–0.88]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationGlucagon-Like Peptide-1 Receptor AgonistsIncretinsObesityAgedFemaleHumansMaleMiddle AgedDatabases, FactualRecurrenceRetrospective StudiesRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

(GLP1) receptor agonistatrial fibrillationbody mass indexcatheter ablationinflammationobesity

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsIncretins

Autor:innen und Institutionen

  • Department of Cardiology, Grenoble Alpes University Hospital, Grenoble, France (S.V., P.D., R.B., A.C., Y.D., P.J.).
  • University Grenoble Alpes, INSERM 1039, LRB, Grenoble, France (S.V., P.D.).
  • Department of Cardiology, Centre Hospitalier Universitaire Trousseau et Faculté de Médecine, Université François Rabelais, Tours, France (L.L., A.B., L.F.).

ORCID-Profile: Sandrine Venier, Pascal Defaye, Lisa Lochon, Arnaud Bisson, Adrien Carabelli, Youssou Diouf, Peggy Jacon, Laurent Fauchier

Zitieren

APA

Venier, S., Defaye, P., Lochon, L., Benali, R., Bisson, A., Carabelli, A., Diouf, Y., Jacon, P., & Fauchier, L. (2026). Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis. Circulation: Arrhythmia and Electrophysiology, 19(1). https://doi.org/10.1161/circep.125.014101

Vancouver

Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A, et al. Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis. Circulation: Arrhythmia and Electrophysiology. 2026;19(1). doi:10.1161/circep.125.014101

BibTeX
@article{Venier2026,
  author = {Venier, Sandrine and Defaye, Pascal and Lochon, Lisa and Benali, Rémi and Bisson, Arnaud and Carabelli, Adrien and Diouf, Youssou and Jacon, Peggy and Fauchier, Laurent},
  title = {Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.1161/circep.125.014101}
}
Kostenlos starten →